Physician profile
Dongyup Lee
NPI 1831713221
$10,752.38
in general payments reported to CMS, 2019-2025
11 companies · $7,242 in 2025
The $7,242 reported for 2025 was more than what 96% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $40.00 · 2024: $3,470 · 2025: $7,242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,691 · Grant: $2,000 · Food and Beverage: $1,905 · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,690.82 |
| Grant | $2,000.00 |
| Food and Beverage | $1,904.61 |
| Education | $156.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,731.30 | 2024-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Abbott Laboratories | $3,060.11 | 2025 | Proclaim, Eterna |
| Saluda Medical Americas, INC. | $1,459.09 | 2025 | Evoke |
| Si-Bone, INC. | $1,279.36 | 2025 | |
| Boston Scientific Corporation | $874.21 | 2025 | General - Therapies, Intracept |
| Spr Therapeutics, INC | $144.33 | 2025 | Sprint Pns System |
| Stryker Corporation | $84.94 | 2025 | Mild Device Kit, Spinejack |
| Abbvie INC. | $59.84 | 2023-2025 | |
| Nalu Medical, INC. | $29.15 | 2025 | Nalu Neurostimulation System |
| Protega Pharmaceutials INC | $15.28 | 2025 | Roxybond |
| Vertex Pharmaceuticals Incorporated | $14.77 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dongyup Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.